Home Recalls D-516-2014
Class II · Moderate risk Terminated Initiated Jul 2, 2013 (13 years ago)
VENLAFAXINE Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714031101
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Labeling: Label Mixup; VENLAFAXINE Tablet, 25 mg may be potentially mislabeled as OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD65457_22, EXP: 5/24/2014.
What was recalled
VENLAFAXINE Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714031101
Recalling firm Aidapak Services, LLC
Origin WA, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-516-2014
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Completed Mar 21, 2025
Reason Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
Class III · Low risk Completed Jan 16, 2025
Reason Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Class II · Moderate risk Terminated Jun 21, 2024
Reason Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
Class II · Moderate risk Terminated Jun 18, 2024
Reason Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.
Class II · Moderate risk Terminated Jul 29, 2021
Reason Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg